This limitation is not an isolated perception. A recent analysis by the World Health Organization of the level of preparedness of European countries shows that The gap between the expectations generated by AI and its actual application remains wide.
The problem lies not only in the available technology, but in the economic and organizational capacity to adopt it in a safe, equitable and sustainable way.
A potential that collides with budgetary reality
European health systems have been facing increasing pressure on their resources for years. The aging of the population, the increase in chronic diseases and the shortage of health professionals force us to look for innovative solutions.
However, according to the report “Artificial intelligence is reshaping health systems: state of readiness across the WHO European Region” According to the WHO, 43 of the 50 Member States surveyed recognize that insufficient funding directly limits the adoption of artificial intelligence in healthcare.
This deficiency affects both the acquisition of technology and the development of infrastructurestaff training and the creation of solid regulatory frameworks.
Impact on diagnosis, care and clinical management
The scarcity of economic resources has very concrete practical consequences. Many AI-assisted diagnostic tools, capable of improving early detection of diseases or reducing clinical errors, are not widely deployed.
The same applies to clinical decision support systems, remote patient monitoring platforms or conversational solutions that could alleviate the administrative burden on healthcare personnel.
Additionally, lack of investment delays clinical validation and integration of these solutions into real-world workflows. Without stable funding, pilot projects remain isolated and do not become structural programs capable of generating large-scale impact.
Training, a pending subject
Another direct effect of limited funding is the lack of specific training in AI within the healthcare sector. The WHO report highlights that many countries do not have sufficient programs to train doctors, nurses and managers in the responsible use of these technologies.
This lack not only slows down adoption, but also increases distrust. Without adequate knowledge, AI is perceived as an opaque and difficult to control tool, which reinforces resistance to change and reduces its acceptance among professionals.
Governance and legal frameworks, also conditioned
Underinvestment affects not only technology or training, but also the development of clear standards. The creation of ethical, legal and data governance frameworks requires technical, legal and human resources that many health systems do not have fully covered.
The WHO warns that this situation can lead to uneven adoption of AI, generating gaps between countries and regions, as well as legal risks for both professionals and patients. Without adequate funding, ensuring safe, transparent and equitable use is particularly complex.
Spain and the European context
Spain shares many of these challenges with other countries around it. Although there are health digitalization plans and general innovation strategies, specific budget allocation for AI in health remains limited.
Investment is concentrated in specific projects, but not always in a comprehensive strategy that encompasses technology, training and regulation.
This situation reflects a common pattern in Europe, where dependence on public and private funds conditions the speed of adoption. The WHO report points out that only a minority of countries have specific national strategies for artificial intelligence in healthcare, which shows a lack of long-term planning.
Risk of inequality in access to care
One of the most concerning aspects of this lack of funding is its impact on equity. If the adoption of AI depends on the economic capacity of each country or region, access to the benefits of these technologies may become unequal.
This contradicts the principles of universality and equity that underpin many European public health systems.
The WHO emphasizes that, without priority investment, AI runs the risk of widening existing gaps rather than narrowing them. Technology, by itself, does not guarantee improvements if it is not accompanied by solid public policies and sufficient financing.
The analysis concludes that artificial intelligence can play a transformative role in European healthcare, but only if economic obstacles are decisively addressed.
Investing in AI does not only mean acquiring software, but also strengthening human capabilities, improving data governance and establish clear rules that protect patients and professionals.